239 related articles for article (PubMed ID: 11707390)
1. Crystal structure of the ankyrin repeat domain of Bcl-3: a unique member of the IkappaB protein family.
Michel F; Soler-Lopez M; Petosa C; Cramer P; Siebenlist U; Müller CW
EMBO J; 2001 Nov; 20(22):6180-90. PubMed ID: 11707390
[TBL] [Abstract][Full Text] [Related]
2. Structure of an IkappaBalpha/NF-kappaB complex.
Jacobs MD; Harrison SC
Cell; 1998 Dec; 95(6):749-58. PubMed ID: 9865693
[TBL] [Abstract][Full Text] [Related]
3. Modulation of p53 activity by IkappaBalpha: evidence suggesting a common phylogeny between NF-kappaB and p53 transcription factors.
Dreyfus DH; Nagasawa M; Gelfand EW; Ghoda LY
BMC Immunol; 2005 Jun; 6():12. PubMed ID: 15969767
[TBL] [Abstract][Full Text] [Related]
4. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
Li J; Joo SH; Tsai MD
Biochemistry; 2003 Nov; 42(46):13476-83. PubMed ID: 14621993
[TBL] [Abstract][Full Text] [Related]
5. Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences.
Sachdev S; Hoffmann A; Hannink M
Mol Cell Biol; 1998 May; 18(5):2524-34. PubMed ID: 9566872
[TBL] [Abstract][Full Text] [Related]
6. Detection of a ternary complex of NF-kappaB and IkappaBalpha with DNA provides insights into how IkappaBalpha removes NF-kappaB from transcription sites.
Sue SC; Alverdi V; Komives EA; Dyson HJ
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1367-72. PubMed ID: 21220295
[TBL] [Abstract][Full Text] [Related]
7. Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.
Hatada EN; Naumann M; Scheidereit C
EMBO J; 1993 Jul; 12(7):2781-8. PubMed ID: 8334994
[TBL] [Abstract][Full Text] [Related]
8. The ankyrin repeats but not the PEST-like sequences are required for signal-dependent degradation of IkappaBalpha.
Aoki T; Sano Y; Yamamoto T; Inoue JI
Oncogene; 1996 Mar; 12(5):1159-64. PubMed ID: 8649809
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation.
Huxford T; Huang DB; Malek S; Ghosh G
Cell; 1998 Dec; 95(6):759-70. PubMed ID: 9865694
[TBL] [Abstract][Full Text] [Related]
10. Solvent exposed non-contacting amino acids play a critical role in NF-kappaB/IkappaBalpha complex formation.
Huxford T; Mishler D; Phelps CB; Huang DB; Sengchanthalangsy LL; Reeves R; Hughes CA; Komives EA; Ghosh G
J Mol Biol; 2002 Dec; 324(4):587-97. PubMed ID: 12460563
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms by which IkappaB proteins control NF-kappaB activity.
Simeonidis S; Stauber D; Chen G; Hendrickson WA; Thanos D
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):49-54. PubMed ID: 9874770
[TBL] [Abstract][Full Text] [Related]
12. PEST-dependent cytoplasmic retention of v-Rel by I(kappa)B-alpha: evidence that I(kappa)B-alpha regulates cellular localization of c-Rel and v-Rel by distinct mechanisms.
Rottjakob EM; Sachdev S; Leanna CA; McKinsey TA; Hannink M
J Virol; 1996 May; 70(5):3176-88. PubMed ID: 8627798
[TBL] [Abstract][Full Text] [Related]
13. The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.
Dechend R; Hirano F; Lehmann K; Heissmeyer V; Ansieau S; Wulczyn FG; Scheidereit C; Leutz A
Oncogene; 1999 Jun; 18(22):3316-23. PubMed ID: 10362352
[TBL] [Abstract][Full Text] [Related]
14. Structure-function relationship of cytoplasmic and nuclear IκB proteins: an in silico analysis.
Manavalan B; Basith S; Choi YM; Lee G; Choi S
PLoS One; 2010 Dec; 5(12):e15782. PubMed ID: 21203422
[TBL] [Abstract][Full Text] [Related]
15. Signal-dependent degradation of IkappaBalpha is mediated by an inducible destruction box that can be transferred to NF-kappaB, bcl-3 or p53.
Wulczyn FG; Krappmann D; Scheidereit C
Nucleic Acids Res; 1998 Apr; 26(7):1724-30. PubMed ID: 9512545
[TBL] [Abstract][Full Text] [Related]
16. Transfer of flexibility between ankyrin repeats in IkappaB* upon formation of the NF-kappaB complex.
Sue SC; Cervantes C; Komives EA; Dyson HJ
J Mol Biol; 2008 Jul; 380(5):917-31. PubMed ID: 18565540
[TBL] [Abstract][Full Text] [Related]
17. Kinetic enhancement of NF-kappaBxDNA dissociation by IkappaBalpha.
Bergqvist S; Alverdi V; Mengel B; Hoffmann A; Ghosh G; Komives EA
Proc Natl Acad Sci U S A; 2009 Nov; 106(46):19328-33. PubMed ID: 19887633
[TBL] [Abstract][Full Text] [Related]
18. IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2.
Prigent M; Barlat I; Langen H; Dargemont C
J Biol Chem; 2000 Nov; 275(46):36441-9. PubMed ID: 10969074
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the IkappaBalpha C-terminal PEST sequence with NF-kappaB: insights into the inhibition of NF-kappaB DNA binding by IkappaBalpha.
Sue SC; Dyson HJ
J Mol Biol; 2009 May; 388(4):824-38. PubMed ID: 19327364
[TBL] [Abstract][Full Text] [Related]
20. X-ray crystal structure of an IkappaBbeta x NF-kappaB p65 homodimer complex.
Malek S; Huang DB; Huxford T; Ghosh S; Ghosh G
J Biol Chem; 2003 Jun; 278(25):23094-100. PubMed ID: 12686541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
